These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

136 related articles for article (PubMed ID: 1208758)

  • 21. Discriminative stimulus properties of substituted amphetamine derivatives.
    Corrigall WA; Coen KM; Saouda FM; Robertson JM; Lodge BA
    Pharmacol Biochem Behav; 1992 Dec; 43(4):1117-9. PubMed ID: 1475294
    [TBL] [Abstract][Full Text] [Related]  

  • 22. (-)-Nornicotine partially substitutes for (+)-amphetamine in a drug discrimination paradigm in rats.
    Bardo MT; Bevins RA; Klebaur JE; Crooks PA; Dwoskin LP
    Pharmacol Biochem Behav; 1997 Dec; 58(4):1083-7. PubMed ID: 9408217
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Comparison of 2, 5-dimethoxy-4-methylamphetamine (DOM) and d-amphetamine for in vivo efflux of catecholamines from rat brain.
    Vrbanac JJ; Tilson HA; Moore KE; Rech RH
    Pharmacol Biochem Behav; 1975; 3(1):57-64. PubMed ID: 1129355
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Hallucinogens as a discriminative stimuli: generalization of DOM to a 5-methoxy-N, N-dimethyltryptamine stimulus.
    Glennon RA; Rosecrans JA; Young R; Gaines J
    Life Sci; 1979 Mar; 24(11):993-7. PubMed ID: 286864
    [No Abstract]   [Full Text] [Related]  

  • 25. Stereoselective effects of 1-(2,5-dimethoxy-4-methylphenyl)-2-aminopropane (DOM) on schedule-controlled behavior.
    Harris RA; Snell D; Loh HH
    Pharmacol Biochem Behav; 1977 Oct; 7(4):307-10. PubMed ID: 928488
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Nefazodone in the rat: mimicry and antagonism of [-]-DOM-induced stimulus control.
    Eckler JR; Rabin RA; Winter JC
    Pharmacol Biochem Behav; 2003 May; 75(2):405-10. PubMed ID: 12873632
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Drug discrimination studies with MDMA and amphetamine.
    Oberlender R; Nichols DE
    Psychopharmacology (Berl); 1988; 95(1):71-6. PubMed ID: 2898791
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Discriminative stimulus properties of a low dl-amphetamine dose.
    Colpaert FC; Kuyps JJ; Niemegeers CJ; Janssen PA
    Arch Int Pharmacodyn Ther; 1976 Sep; 223(1):34-42. PubMed ID: 999400
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Enhancement of the behavioral effects of 2,5-dimethoxy-4-methyl-amphetamine (DOM) by pretreatment with p-chlorophenylalanine.
    Commissaris RL; Lyness WH; Moore KE; Rech RH
    Pharmacol Biochem Behav; 1980 Oct; 13(4):605-8. PubMed ID: 6449015
    [TBL] [Abstract][Full Text] [Related]  

  • 30. The reinforcing and discriminative stimulus properties of para-ethoxy- and para-methoxyamphetamine.
    Corrigall WA; Robertson JM; Coen KM; Lodge BA
    Pharmacol Biochem Behav; 1992 Jan; 41(1):165-9. PubMed ID: 1539067
    [TBL] [Abstract][Full Text] [Related]  

  • 31. The effects of 2,5-dimethoxy-4-methylamphetamine (DOM) on operant behavior: interactions with other neuroactive agents.
    Commissaris RL; Semeyn DR; Moore KE; Rech RH
    Commun Psychopharmacol; 1980; 4(5):393-404. PubMed ID: 6120791
    [No Abstract]   [Full Text] [Related]  

  • 32. Stimulus properties of thyrotropin-releasing hormone.
    Jones CN; Grant LD; Prange AJ
    Psychopharmacology (Berl); 1978 Dec; 59(3):217-24. PubMed ID: 104325
    [TBL] [Abstract][Full Text] [Related]  

  • 33. The 5-HT3 receptor partial agonist MD-354 (meta-chlorophenylguanidine) enhances the discriminative stimulus actions of (+)amphetamine in rats.
    Dukat M; Wesolowska A; Young R; Glennon RA
    Pharmacol Biochem Behav; 2007; 87(2):203-7. PubMed ID: 17540440
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Temporal parameters of d-amphetamine as a discriminative stimulus in the rat.
    Jones CN; Grant LD; Vospalek DM
    Psychopharmacologia; 1976; 46(1):59-64. PubMed ID: 1257368
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Discriminative stimulus effects of 1-(2,5-dimethoxy-4-methylphenyl)-2-aminopropane in rhesus monkeys.
    Li JX; Rice KC; France CP
    J Pharmacol Exp Ther; 2008 Feb; 324(2):827-33. PubMed ID: 17993605
    [TBL] [Abstract][Full Text] [Related]  

  • 36. DOM and related 2,5-dimethoxy-4-alkylphenylisopropylamines: behavioral and serotonin receptor properties.
    Glennon RA; Doot DL; Young R
    Pharmacol Biochem Behav; 1981 Mar; 14(3):287-92. PubMed ID: 7232455
    [TBL] [Abstract][Full Text] [Related]  

  • 37. The time-dependent stimulus effects of R(-)-2,5-dimethoxy-4-methamphetamine (DOM): implications for drug-induced stimulus control as a method for the study of hallucinogenic agents.
    Fiorella D; Palumbo PA; Rabin RA; Winter JC
    Psychopharmacology (Berl); 1995 May; 119(2):239-45. PubMed ID: 7659772
    [TBL] [Abstract][Full Text] [Related]  

  • 38. MDMA-like stimulus effects of alpha-ethyltryptamine and the alpha-ethyl homolog of DOM.
    Glennon RA
    Pharmacol Biochem Behav; 1993 Oct; 46(2):459-62. PubMed ID: 7903460
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Lack of generalization of nisoxetine with amphetamine in the rat.
    Schechter MD; Boja JW
    Pharmacol Biochem Behav; 1988 Aug; 30(4):1085-8. PubMed ID: 3265789
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Facilitatory and inhibitory actions of morphine on the discriminative stimulus properties of D-amphetamine.
    Gaiardi M; Bartoletti M; Gubellini C
    Pharmacol Res; 1998 Nov; 38(5):333-7. PubMed ID: 9806811
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.